CRGX241220C22500
- 0.00
- 0.000.00%
CARGO Therapeutics Newsroom
Cargo Therapeutics Analyst Ratings
William Blair Initiates CARGO Therapeutics(CRGX.US) With Buy Rating
H.C. Wainwright Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $33
Promising Outlook for Cargo Therapeutics: Buy Rating Backed by Strong Financials and Clinical Developments
Truist Financial Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $32
Chardan Capital Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $28
Cargo Therapeutics Analyst Ratings
Chardan Capital Maintains Buy on Cargo Therapeutics, Maintains $28 Price Target
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $34
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $34
J.P. Morgan Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $30
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $34
Truist Financial Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $32
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Cuts Target Price to $34
Cargo Therapeutics Analyst Ratings
Piper Sandler Maintains Overweight on Cargo Therapeutics, Lowers Price Target to $34
H.C. Wainwright Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $33
CARGO Therapeutics Price Target Announced at $33.00/Share by HC Wainwright & Co.
Cargo Therapeutics Analyst Ratings
Cargo Therapeutics Analyst Ratings